July, 23 2019
Giving healthcare companies the exposure they deserve. Every Tuesday.
BioTuesdays by Kilmer Lucas


PharmaCyte’s Cell-in-a-Box encapsulation technology targeting cancer, diabetes

PharmaCyte Biotech (OTCQB:PMCB) is developing cellular therapies for its lead pancreatic cancer program and for diabetes that are based on a proprietary cellulose-based live cell encapsulation technology known as a Cell-in-a-Box. 

“When used for pancreatic cancer treatment, the combination of Cell-in-a-Box encapsulation plus a cancer prodrug, which needs to be converted to its cancer-killing form by the cells in the Cell-in-a-Box capsules, turns out to be a completely unique approach to the treatment of pancreatic cancer,” CEO, president and general counsel, Kenneth L. Waggoner, says in an interview with BioTuesdays.

“In very early clinical trials, this combination produced a strong antitumor effect at the tumor site, with little-to-no treatment-related side effects,” he adds.

Mr. Waggoner explains that to treat pancreatic cancer, PharmaCyte’s platform technology encapsulates genetically modified live cells that are used with a cancer prodrug, ifosfamide. These modified encapsulated cells are implanted in the blood supply as close as possible to the tumor site. 
Read the Story




Emerging liver disease company, ContraVir, changes name to Hepion Pharmaceuticals; stock symbol to “HEPA”



Arranges $10-million of non-dilutive financing in supply pact with Starseed Medicinal




Prices $35-million equity offering




Taps industry veteran, Robert Bruce, as CEO

More Briefs

Wall Street News

About BioTuesdays

BioTuesdays was created in 2009 by Kilmer Lucas, a leading healthcare-only investor relations firm. Employing a unique "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR & PR programs for its drug development, medical device, cell therapy, diagnostics and healthcare services clients. But, most of BioTuesdays' content isn't client-driven. Rather, our mission is to give as many great healthcare companies and their stories as much exposure as we can.
Want to be featured in BioTuesdays? Get in touch with us.
Copyright © 2019 Kilmer Lucas, All rights reserved.
You are receiving this email because you signed up for the BioTuesdays newsletter.
Privacy Policy

PO Box 297
Carlisle, ON L0R 1H0 

subscribe | unsubscribe | update your preferences